Anaptysbio (ANAB) Revenue (2016 - 2026)
Anaptysbio (ANAB) reported Revenue of $27.49 million for Q2 2026, up 23.5% from $22.26 million a year earlier and up 7.6% from the prior quarter.
Powered by 
Analysis
Anaptysbio (ANAB) Revenue (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Anaptysbio's Revenue came in at $237.61 million, up 92.9% year-over-year; for FY2025, it was $234.6 million, up 157.0% from FY2024.
- Revenue has increased for three consecutive years, with a five-year compound annual growth rate of 25.6% (FY2020 to FY2025).
- By year, Revenue came in at $91.28 million in FY2024 (+432.0%), $17.16 million in FY2023 (+66.8%), $10.29 million in FY2022 (-83.7%) and $63.18 million in FY2021 (-15.8%).
- Five-year quarterly Revenue spans a low of $970,000 in Q1 2022 and a high of $108.25 million in Q4 2025.
- Year over year, Revenue gained in seven of the last eight quarters, with growth averaging 236.8%.
- The high point for year-over-year Revenue in five years was Q3 2024 (growth of 804.7%); the low point was Q4 2021 (a decline of 98.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $25.56 million (Q1 2026), $108.25 million (Q4 2025) and $76.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 24.40 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 17.40 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 18.09 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 16.58 Bn |
| 10 | Anaptysbio | 1.39 Bn | 274.02 Mn | - | 25.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 25.56 Mn |
| Dec 31, 2025 | 108.25 Mn |
| Sep 30, 2025 | 76.32 Mn |
| Jun 30, 2025 | 22.26 Mn |
| Mar 31, 2025 | 27.77 Mn |
| Dec 31, 2024 | 43.11 Mn |
| Sep 30, 2024 | 30.02 Mn |
| Jun 30, 2024 | 10.97 Mn |
| Mar 31, 2024 | 7.18 Mn |
| Dec 31, 2023 | 9.01 Mn |
| Sep 30, 2023 | 3.32 Mn |
| Jun 30, 2023 | 3.46 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2022 | 6.81 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | 970,000.00 |
| Dec 31, 2021 | 1.01 Mn |
| Sep 30, 2021 | 20.89 Mn |
| Jun 30, 2021 | 30.03 Mn |
API Access
Anaptysbio Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();